| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.09 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.03 | 0.8 |